Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial	Hemic and Lymphatic Diseases, Neoplasm, Lymphatic Tissue, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, immune system disorder, immunoproliferative disorder, lymphangioleiomyomatosis, lymphangiomyoma, lymphatic system disorder, lymphoproliferative syndrome, neoplasm, neoplasm with perivascular epithelioid cell differentiation	Active, not recruiting	Phase 3	2024-12-24		NCT03150914

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
National Center for Advancing Translational Sciences (NCATS)	127
National Heart, Lung, and Blood Institute (NHLBI)	791
The LAM Foundation	2
University of Cincinnati	87

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Brigham and Woman's Hospital	Boston	United States	1
Emory University	Atlanta	United States	262
Loyola University	Chicago	United States	2
National Jewish Hospital	Denver	United States	1
Stanford University	Palo Alto	United States	51
Swedish Health	Seattle	United States	1
University of Cincinnati	Cincinnati	United States	1
University of Pennsylvania	Philadelphia	United States	507